Table 4.
Association of different components of metabolic syndrome and the development of hepatocellular carcinoma
Author | Type of Study | Risk Parameter | Obesity | DM | Hyperlipidemia | HTN |
Larsson et al[35] | Meta analysis | RR | 1.85 | |||
Calle et al[37] | Prospective | RR | 4.52 (Male) | |||
1.68 (Female) | ||||||
Welzel et al[40] | Retrospective | OR | 1.93 | 2.9 | 1.35 | 2.2 |
Borena et al[25] | Prospective | RR | 1.39 | 2.13 | 0.85 | 2.08 |
Turati et al[48] | Retrospective | OR | 1.97 | 4.33 | ||
Davila et al[42] | Retrospective | OR | 2.87 | |||
Lagiou et al[43] | Prospective | RR | 4.5 (Male) | |||
1.86 (Female) | ||||||
El-Serag et al[46] | Prospective | RR | 2 | |||
Tomimaru et al[55] | Prospective | RR | 82.2 (with cirrhosis) |
RR: Relative risk; OR: Odd ratio; DM: Diabetes mellitus; HTN: Hypertension.